CancerTools offers a wide range of monoclonal, polyclonal and recombinant antibodies, for research in DNA damage and repair, proliferation, regulated cell death, cell signalling and adhesion, tumour microenvironment, inflammation and immunophenotyping.
To meet your needs, we offer customised formulations of our antibody collection, including carrier-free. If you need to scale up your project or can’t find the right combination of antibody and label of interest, our antibodies can also be ordered in large volumes and/or with customised conjugation, giving the flexibility you need for your experiments.
Synthetic peptide (CTRSRS ERDVLLDEPP QGLYDAVRLR E) as part of rat Vesicular Acetylcholine Transporter, VACHT (accession: NP_113851) Conjugated to Blue Carrier Protein.
Synthetic peptide as part of human Ubiquitin Interactive Motif (UIM) derived from p62 protein, also known as SQSTM1 conjugated to Keyhole Limpet Hemocyanin (KLH). (accession: AAH01874)
A 20 amino acid synthetic Ara h1 (Arachis hypogaea 1) peptide conjugated to Keyhole Limpet Hemocyanin (KLH). The peptide sequence is located near the middle region of Ara h1 protein sequence. Ara h1 is a major allergen that causes IgE mediated sensitization in up to 95% of patients with peanut allergy. It has a molecular weight of 70 kDa and acts as a nutrient reservoir
A 21 amino acid synthetic Arah 2/6 (Arachis hypogaea 2) Peptide conjugated to Keyhole Limpet Hemocyanin (KLH). Ara h2 is a major peanut allergen. Ara h 2 purified from peanuts is homologous to and functions as a trypsin inhibitor. Due to similarities in Ara h 2 and 6 sequences, this Antibody recognises both allergens.
A 20 amino acid synthetic Ara h2 (Arachis hypogaea 2) Peptide conjugated to Keyhole Limpet Hemocyanin (KLH). The peptide sequence is located near the middle region of Ara h2 protein sequence. Ara h2 is a major peanut allergen and exists in 2 isoforms, Ara h2.0101 and Ara h2.0201 of Mw 18.7 and 20.1 kDa respectively. Ara h2 is a seed storage protein and has weak trypsin inhibitor activity. The antibody recognizes both isoforms.
Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.
